Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05203302 · ClinicalTrials.gov registry record · NA
Novel Coding Strategies for Children With Cochlear Implants
A NA study of Deafness, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 190
- Enrollment target
- 1
- Study location
NCT05203302: Recruiting NA study of Deafness, sponsored by NYU Langone Health.
NCT05203302 is a NA study of Deafness that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 190 participants, below the 600-participant average among 11 other Deafness trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05203302, a NA study of Deafness, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand performance with a cochlear implant. The long-term goals of this research are to improve sound perception with cochlear implants and to better understand the functioning of the auditory system. Information from individuals with and without cochlear implants will be compared.
Primary Outcome
Power functions will be fit for each of the loudness growth curves. Data will be analyzed using a mixed-design ANOVA with the two groups as the between-subjects factor and electrode and rate as within-subject factors.
Conditions Studied
Interventions
- OTHER Single-Electrode Pulse Train
- OTHER Modulation Detection Threshold (MDT) and Gap Detection Tasks
- OTHER Sound coding strategy.
- OTHER Electric-only spectral resolution
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
What NCT05203302 shows while recruiting
NCT05203302 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 600-participant average among 11 other Deafness trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Deafness appearing as the primary indexed condition, and to 4 interventions - of which Single-Electrode Pulse Train is the first listed.
NCT05203302 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05203302 about?
NCT05203302 is a clinical study titled "Novel Coding Strategies for Children With Cochlear Implants". The purpose of this study is to understand performance with a cochlear implant. The long-term goals of this research are to improve sound perception with cochlear implants and to better understand the functioning of the auditory system. Information from individuals with and without cochlear implants...
What is the current status of trial NCT05203302?
This trial is currently recruiting. It is a NA study. The enrollment target is 190 participants. The study started on 2018-07-12. Estimated completion is 2027-01-01.
What conditions does trial NCT05203302 study?
This clinical trial studies the following conditions: Deafness.
What interventions are being tested in trial NCT05203302?
The interventions under investigation include: Single-Electrode Pulse Train (OTHER), Modulation Detection Threshold (MDT) and Gap Detection Tasks (OTHER), Sound coding strategy. (OTHER), Electric-only spectral resolution (OTHER).
Who is sponsoring clinical trial NCT05203302?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05203302 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Deafness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05203302's enrollment target sits among peer trials
190 6th of 11 higher than 6 of 11 other Deafness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Deafness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants
RECRUITING · NA
-
Word Learning in Deaf Children Using Eye-tracking and Behavioral Measures
RECRUITING · NA
-
Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy
RECRUITING · NA
-
Hearing Program in Primary Care
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI